Nebraska Cancer Specialists

Summary

Nebraska Cancer Specialists is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Nebraska Cancer Specialists is involved with conducting 178 clinical trials across 229 conditions. There are 7 research doctors associated with this hospital, such as Ralph Hauke, MD, Timothy Huyck, Robert M. Langdon, and Samuel Mehr.

Top PIs

Clinical Trials running at Nebraska Cancer Specialists

Cancer

Lung Cancer

Colorectal Cancer

Breast Cancer

Prostate Cancer

Pancreatic Cancer

Multiple Myeloma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Stomach Cancer

CCS1477

for Blood Cancers

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.

Recruiting

3 awards

Phase 1 & 2

5 criteria

Bria-IMT + CPI

for Advanced Breast Cancer

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.

Recruiting

2 awards

Phase 3

6 criteria

RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant

for Breast Cancer

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.

Recruiting

2 awards

Phase 3

5 criteria